搜索结果
ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
---|
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN058311 | pinosylvin | (trans)-3,5-stilbenediol; LS-146810; W2082; 5-[(E)-2-PHENYLETHENYL]-1,3-BENZENEDIOL; 5-[(E)-2-phenylvinyl]benzene-1,3-diol; 3,5-Dihydroxystilbene; NSC-362430; BRN 1870942; 1,3-Benzenediol,5-[(1E)-2-phenylethenyl]-; ZINC901115; A815968; PubChem19089; AC-7928; MolPort-000-880-993; UNII-75IT683K8W component YCVPRTHEGLPYPB-VOTSOKGWSA-N; trans-pinosylvin; 1,3-Benzenediol, 5-(2-phenylethenyl)-, (E)-; D33B05BD-8441-4288-A247-D461C3D1F1CA; 5-(2-phenylethenyl)benzene-1,3-diol; LMPK13090001; NSC362430; NSC 362430; AKOS000276828; 22139-77-1; AK162490; 5-[(1E)-2-phenylethenyl]benzene-1,3-diol; SDCCGMLS-0066433.P001; BC657151; I14-6890; 5-[(E)-styryl]benzene-1,3-diol; 102-61-4; (E)-5-(2-Phenylethenyl)-1,3-benzenediol; 1,3-Benzenediol, 5-(2-phenylethenyl)-; NCGC00179033-01; 5-[(E)-2-phenylethenyl]benzene-1,3-diol; 5-(2-phenylvinyl)benzene-1,3-diol; C01745; pound inverted question markPinosylvin; Pinosylvin; CCG-38399; 5-(2-phenylethenyl)-1,3-benzenediol; AX8015298; BSPBio_001753; 3,5-stilbenediol; 5-Styrylresorcinol; AC1NQX1Y; Pinosylvin, >=97.0% (HPLC); (E)-5-Styrylbenzene-1,3-diol; 3-06-00-05577 (Beilstein Handbook Reference); UNII-881R434AIB; SC-20584; Stilbene, 3,5-dihydroxy-, trans-; Pinosylvine; (E)-3,5-stilbenediol; Stilbene, 1f; BDBM50045924; Spectrum5_000307; 1,3-Benzenediol, 5-[(1E)-2-phenylethenyl]-; MolPort-044-723-416; 881R434AIB; 139P771; ZB015246; SCHEMBL454262; 3,5-dihydroxy-trans-stilbene; 3,5-Stilbenediol, (E)-; CHEBI:17323; ST51054405; trans-3,5-Dihydroxystilbene; BRD-K94645280-001-02-1; (E)-pinosylvin; AC1Q7AYY; ST24035072; CHEBI:36011; CHEMBL101506;3,5-dihydroxystilbene | C14H12O2 | 212.24 g/mol | C1=CC=C(C=C1)C=CC2=CC(=CC(=C2)O)O |
疾病ID | 疾病名 | MeSH名 | HPO名 | UMLS名 | 疾病类型 |
---|
TCMBANKDI000076 | Neoplasms | - | Neoplastic Process | group | |
TCMBANKDI004145 | Mental Disorders | Abnormality of the nervous system | Mental or Behavioral Dysfunction | group | |
TCMBANKDI009278 | Mental Disorders | - | Mental or Behavioral Dysfunction | group | |
TCMBANKDI010160 | Respiratory Tract Diseases | Abnormality of the respiratory system | Disease or Syndrome | group | |
TCMBANKDI012074 | Neoplasms; Female Urogenital Diseases and Pregnancy Complications | Abnormality of prenatal development or birth; Abnormality of the genitourinary system; Neoplasm | Neoplastic Process | disease | |
TCMBANKDI012932 | Infections; Immune System Diseases | - | Disease or Syndrome | group | |
TCMBANKDI015485 | Mental Disorders | Abnormality of the nervous system | Mental or Behavioral Dysfunction | disease | |
TCMBANKDI015757 | Infections | - | Disease or Syndrome | disease | |
TCMBANKDI016386 | Infections; Immune System Diseases | - | Disease or Syndrome | disease | |
TCMBANKDI016994 | Infections; Nervous System Diseases | - | Disease or Syndrome | disease | |
TCMBANKDI017474 | - | - | Disease or Syndrome | disease | |
TCMBANKDI026360 | Infections | - | Disease or Syndrome | disease | |
TCMBANKDI029241 | Infections; Immune System Diseases | - | Disease or Syndrome | disease | |
TCMBANKDI029899 | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplasm; Abnormality of blood and blood-forming tissues | Neoplastic Process | group | |
TCMBANKDI030078 | Infections; Nervous System Diseases | - | Disease or Syndrome | disease | |
TCMBANKDI030540 | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | Abnormality of the genitourinary system; Neoplasm | Neoplastic Process | disease | |
TCMBANKDI031211 | Infections; Immune System Diseases; Nervous System Diseases; Mental Disorders | - | Disease or Syndrome | disease |